KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

West Pharmaceutical Services (WST) Interest Expenses (2016 - 2026)

West Pharmaceutical Services has reported Interest Expenses over the past 18 years, most recently at $1.9 million for Q1 2026.

  • Quarterly Interest Expenses rose 375.0% to $1.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Mar 2026, up 11.11% year-over-year, with the annual reading at $500000.0 for FY2025, 83.33% down from the prior year.
  • Interest Expenses was $1.9 million for Q1 2026 at West Pharmaceutical Services, up from -$200000.0 in the prior quarter.
  • Over five years, Interest Expenses peaked at $2.9 million in Q3 2023 and troughed at -$800000.0 in Q4 2024.
  • The 5-year median for Interest Expenses is $1.6 million (2024), against an average of $1.3 million.
  • Biggest five-year swings in Interest Expenses: crashed 166.67% in 2024 and later soared 375.0% in 2026.
  • Tracing WST's Interest Expenses over 5 years: stood at $1.7 million in 2022, then decreased by 29.41% to $1.2 million in 2023, then tumbled by 166.67% to -$800000.0 in 2024, then surged by 75.0% to -$200000.0 in 2025, then soared by 1050.0% to $1.9 million in 2026.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $1.9 million, -$200000.0, and $200000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.